Related references
Note: Only part of the references are listed.Observed frequency and challenges of variant reclassification in a hereditary cancer clinic
Sarah Macklin et al.
GENETICS IN MEDICINE (2018)
ClinVar: improving access to variant interpretations and supporting evidence
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2018)
Inherited Cancer in the Age of Next-Generation Sequencing
Kristin S. Price et al.
BIOLOGICAL RESEARCH FOR NURSING (2018)
BRCA1/2 testing: therapeutic implications for breast cancer management
Nadine M. Tung et al.
BRITISH JOURNAL OF CANCER (2018)
Targeting DNA repair: the genome as a potential biomarker
Ksenija Nesic et al.
JOURNAL OF PATHOLOGY (2018)
Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center
Angela Apessos et al.
CANCER GENETICS (2018)
Points to consider for sharing variant-level information from clinical genetic testing with ClinVar
Danielle R. Azzariti et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2018)
Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory
Sabrina A. Gardner et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2018)
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
Sarah S. Kalia et al.
GENETICS IN MEDICINE (2017)
UniProt: the universal protein knowledgebase
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2017)
panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics
Gundula Povysil et al.
HUMAN MUTATION (2017)
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Elizabeth M. Swisher et al.
LANCET ONCOLOGY (2017)
Compromised BRCA1-PALB2 interaction is associated with breast cancer risk
T. K. Foo et al.
ONCOGENE (2017)
Familial breast cancer: Genetic counseling over time, including patients A expectations and initiators considering the Angelina Jolie effect
Christina Evers et al.
PLOS ONE (2017)
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Olga Kondrashova et al.
CANCER DISCOVERY (2017)
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients
Beth Crawford et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Lisa R. Susswein et al.
GENETICS IN MEDICINE (2016)
Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the Angelina Jolie Effect
Christine Staudigl et al.
BMC CANCER (2016)
Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer
Nadine Tung et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Characterization of Greater Middle Eastern genetic variation for enhanced disease gene iscovery
Eric M. Scott et al.
NATURE GENETICS (2016)
Management of Incidental Findings in the Era of Next-generation Sequencing
Heather L. Blackburn et al.
CURRENT GENOMICS (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Evaluation of Hybridization Capture Versus Amplicon-Based Methods for Whole-Exome Sequencing
Eric Samorodnitsky et al.
HUMAN MUTATION (2015)
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial
Xi-Chun Hu et al.
LANCET ONCOLOGY (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Frequency of Mutations in Individuals With Breast Cancer Referred for BRCA1 and BRCA2 Testing Using Next-Generation Sequencing With a 25-Gene Panel
Nadine Tung et al.
CANCER (2015)
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
Chengliang Dong et al.
HUMAN MOLECULAR GENETICS (2015)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Risk of Colorectal Cancer for Carriers of Mutations in MUTYH, With and Without a Family History of Cancer
Aung Ko Win et al.
GASTROENTEROLOGY (2014)
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
Holly LaDuca et al.
GENETICS IN MEDICINE (2014)
The Effect of CHEK2 Variant I157T on Cancer Susceptibility: Evidence from a Meta-Analysis
Fei-fei Han et al.
DNA AND CELL BIOLOGY (2013)
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Robert C. Green et al.
GENETICS IN MEDICINE (2013)
The CHEK2 I157T Variant and Breast Cancer Susceptibility: A Systematic Review and Meta-analysis
Chuan Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
The CHEK2 I157T Variant and Colorectal Cancer Susceptibility: A Systematic Review and Meta-analysis
Chuan Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
PALB2 self-interaction controls homologous recombination
Remi Buisson et al.
NUCLEIC ACIDS RESEARCH (2012)
Kaviar: an accessible system for testing SNV novelty
Gustavo Glusman et al.
BIOINFORMATICS (2011)
LOVD v.2.0: The Next Generation in Gene Variant Databases
Ivo F. A. C. Fokkema et al.
HUMAN MUTATION (2011)
Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer
Aung Ko Win et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer
Maria C. Villarroel et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The analysis of 2 x 2 contingency tables-Yet again
John T. E. Richardson
STATISTICS IN MEDICINE (2011)
Detection of nonneutral substitution rates on mammalian phylogenies
Katherine S. Pollard et al.
GENOME RESEARCH (2010)
Identifying novel constrained elements by exploiting biased substitution patterns
Manuel Garber et al.
BIOINFORMATICS (2009)
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Feng Zhang et al.
CURRENT BIOLOGY (2009)
PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization
Shirley M. -H. Sy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
Fan Zhang et al.
MOLECULAR CANCER RESEARCH (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Shirley M. H. Sy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
MUTYH Associated Polyposis (MAP)
M. L. M. Poulsen et al.
CURRENT GENOMICS (2008)
Comments on 'Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations'
Antonio Martin Andres
STATISTICS IN MEDICINE (2008)
Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations
Ian Campbell
STATISTICS IN MEDICINE (2007)
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe et al.
CANCER RESEARCH (2006)
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral
SV Tavtigian et al.
JOURNAL OF MEDICAL GENETICS (2006)
Hereditary cancer predisposition syndromes
JE Garber et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Highly penetrant hereditary cancer syndromes
R Nagy et al.
ONCOGENE (2004)
Share Paper
